Andrew S. Davis - 03 Jan 2023 Form 4 Insider Report for Silk Road Medical Inc

Role
Chief Commercial Officer
Signature
/s/Mhairi Jones, by power of attorney
Issuer symbol
N/A
Transactions as of
03 Jan 2023
Net transactions value
-$341,287
Form type
4
Filing time
04 Jan 2023, 19:03:37 UTC
Previous filing
02 Dec 2022
Next filing
03 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SILK Common Stock Options Exercise $8,280 +5,175 +5.3% $1.60* 103,380 03 Jan 2023 Direct F1
transaction SILK Common Stock Sale $273,602 -5,175 -5% $52.87 98,205 03 Jan 2023 Direct F1
transaction SILK Common Stock Options Exercise $7,464 +1,578 +1.6% $4.73 99,783 03 Jan 2023 Direct F1
transaction SILK Common Stock Sale $83,429 -1,578 -1.6% $52.87 98,205 03 Jan 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SILK Option (right to buy) Options Exercise $0 -5,175 -19% $0.000000 22,033 03 Jan 2023 Common Stock 5,175 $1.60 Direct F1, F2
transaction SILK Option (right to buy) Options Exercise $0 -1,578 -2.5% $0.000000 61,618 03 Jan 2023 Common Stock 1,578 $4.73 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on May 20, 2022.
F2 All of the shares subject to this option are fully vested and exercisable as of the date hereof.